Authors
Latest:
Pipeline: New therapies to come for debilitating eye diseasesNew drug from Gensight Biologics hits pipeline
Latest:
Shared care of the ocular surface before and after cataract surgeryPractices must efficiently integrate optometry and ophthalmology, delegating appropriate care to the proper specialist, in order to ensure patients’ total eye care needs are best met.
Latest:
The Impressions and Takeaways from Patient Case No. 2An expert underscores the importance of a comprehensive dry eye examination and offers insights on distinguishing it from neurotrophic keratitis.
Latest:
The white cane and beyond: Part 2Navigation and orientation technologies offer practical solution for people with vision loss.
Latest:
AAOpt 2022: A collaborative approach to pediatric keratoconus offers positive patient outcomesChristina Twardowski, OD, FAAO, and Erin D. Stahl, MD, share highlights from their discussion titled, "A collaborative approach to pediatric keratoconus," which they presented during the 2022 American Academy of Optometry meeting.
Latest:
Nerve growth factor: From discovery to development for human useThe evolution opens doors for the treatment of neurotrophic keratitis and beyond.
Latest:
ASCRS 2023: Laser scleral microporation from Ace Vision GroupMitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.
Latest:
A sneak peek into the Vision Expo East 2025 show floorAshley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.
Latest:
Getting started: methods of initial scleral lens selectionConsider 2 approaches when fitting patients.
Latest:
Brainstorming eye care research expansion with unlimited resourcesFrom contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Latest:
Qlaris Bio announces development of QLS-111-FDCThis new QLS-111 and latanoprost fixed-dose combination (QLS-111-FDC; Qlaris) is in development for the treatment of primary open angle glaucoma, ocular hypertension, and normal tension glaucoma for patients whom optimal intraocular pressure control may remain “unachievable” due to needing to lower episcleral venous pressure.
Latest:
FDA approves Amneal formulation of prednisolone acetate ophthalmic solution 1%The generic formulation references Pred Forte, which is trademarked by Allergan.
Latest:
CCS 2025: Minimizing risk in comanagement as an eye care providerLori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Latest:
Seeing patients eye to eyeHonest discussions about treatments for dry eye disease can enhance compliance and simplify care.
Latest:
Pregnancy and postpartum ophthalmic changes can present a challengeSerious pathologies require high index of suspicion for diagnosis, management
Latest:
Finding the right fit as an LGBTQIA ODSometimes it takes several tries before settling into an inclusive practice that’s right for you.
Latest:
AAOpt 2022: A collaborative approach to pediatric keratoconus offers positive patient outcomesChristina Twardowski, OD, FAAO, and Erin D. Stahl, MD, share highlights from their discussion titled, "A collaborative approach to pediatric keratoconus," which they presented during the 2022 American Academy of Optometry meeting.
Latest:
Preparation is key to fighting dry eye while travelingBest practices to help patients enjoy their trip to the fullest.
Latest:
Delaying myopia onset with Dr. Jeffrey WallineWalline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Latest:
AAOpt 2024: Acknowledging ophthalmic home remedies to build patient trustDamaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Latest:
EnVision Summit 2025: Education for all ages and levels of expertiseBonnie An Henderson, MD, cofounder and program director of EnVision Summit, shares some of the unique qualities of the youth program.
Latest:
EyeCon 2024: Taking a multidisciplinary approach to diabetic eye careMark Dunbar, OD, FAAO, emphasizes the critical role optometrists play in the collaborative care of diabetic eye disease.
Latest:
Patient experiences sudden decrease in visionImaging shows optic disc swelling and retinal nerve fiber layer thickening
Latest:
ARVO 2025: Exploring a conversion factor between 2 OCT devices to monitor glaucoma progressionHammond and his team focused on creating a reliable conversion factor between 2 widely used optical coherence tomography (OCT) systems—the TopCon Maestro2 and the ZEISS Cirrus 5000. Their work specifically looked at ganglion cell–inner plexiform layer and retinal nerve fiber layer thickness measurements, which are critical markers in glaucoma diagnosis and monitoring.
